Navigation Links
CORBETT ACCEL HEALTHCARE GROUP SELECTS ITS CMO: Veteran Brand Builder, Elisa Cooper-Broski, Will Lead Company's Marketing Initiatives
Date:12/10/2007

CHICAGO, Dec. 10 /PRNewswire/ -- Corbett Accel Healthcare Group has selected Elisa Cooper-Broski, a 30-year agency veteran, to serve as its new Executive Vice President and Chief Marketing Officer (CMO). Cooper-Broski will direct Corbett Accel's business development strategy, lead the brand-building efforts for the company's five business units in conjunction with the business unit leaders, and reinforce its competitive position in the marketplace. Cooper-Broski will be based in Corbett Accel's New York office and will report directly to Scott D. Cotherman, Chief Executive Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051117/CGTH066LOGO-a)

"The CMO role is relatively unknown in pharmaceutical advertising," noted Cotherman. "We are one of the first to identify the value a chief marketing officer brings to an organization. Elisa Cooper-Broski's extensive knowledge of the pharmaceutical industry, along with her multi-faceted experience, will be invaluable as we advance our integrated business development strategy."

Cooper-Broski has a proven track record in building global brands, directing teams, and identifying and winning new business. She brings nearly 30 years experience in turning agencies into high-performance companies. She has succeeded in elevating GSW New York's presence in the East Coast, and had been highly instrumental in building this agency's business. Cooper-Broski has served in other leadership positions that include: Saatchi & Saatchi Healthcare (formerly Klemtner Advertising); CommonHealth USA; and NCI Advertising (formerly Rolf Werner Rosenthal). Prior to joining Corbett Accel, Cooper-Broski was President and Chief Branding Officer for Bruce Leeb & Company, a privately held healthcare advertising agency. An accomplished creative strategist and speaker, Cooper-Broski has presented at national conferences and served as a thought leader in various publications.

"Corbett Accel has a strong reputation as an organization with a successfully established supra-culture, one that attracts and nurtures the most creative and strategic talent in all disciplines," said Cooper-Broski. "In this environment, my role as CMO will strengthen the overall impact of Corbett Accel and its business units in the pharmaceutical industry as a communications company that delivers visionary results with substantial and beneficial outcomes. I am delighted to play such an integral role in this outstanding culture and to work with such passionate leaders."

Corbett Accel Healthcare Group (http://www.corbettaccel.com) is one of the largest healthcare communications companies in the world and a part of Omnicom Group Inc. (NYSE: OMC) (http://www.omnicomgroup.com). Corbett Accel business units include Corbett Worldwide Healthcare Communications and Surge Worldwide Healthcare Communications, both of which offer professional healthcare advertising, branding and promotions; Iris Global Clinical Trial Solutions; Kinect, a full-service interactive agency; and Accel Health, a promotional medical education agency.

Omnicom is a leading global advertising, marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 100 countries.


'/>"/>
SOURCE Corbett Accel Healthcare Group
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
3. Pregnancy may slow -- not accelerate -- progression to AIDS
4. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
5. RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US
6. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
7. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
11. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... 2016 , ... The Society for Women’s Health Research (SWHR) announced that its ... role. , “No one in Washington led the way to advance women’s health research ... MD, PhD. “We offer our deep gratitude to Phyllis for her passion and performance ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley ... worldwide for people who are blind or visually impaired, announces the election of ... President Charles E. Young. Hadley’s Board of Trustees retained Morris & Berger, a ...
(Date:5/23/2016)... ... May 23, 2016 , ... Four Circles Recovery Center, a leading treatment ... to announce the launch of its new extended care program, Fifth Circle. Available for ... Four Circles or another primary treatment program, Fifth Circle is designed to foster the ...
(Date:5/23/2016)... ... 23, 2016 , ... Bio-Optronics, Inc. is delighted to announce ... its recent and anticipated growth. , Max Elbaz was appointed as Vice President, ... segments. Max joined the Bio-Optronics team in March. His areas of expertise include ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... 19, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... the treatment of multiple cancer and hematological indications, will ... An abstract titled " Clinical response in relapsed/refractory AML ... by BL-8040, a potent CXCR4 antagonist; results of a ... presentation at the European Hematology Association 21st Congress, to ...
(Date:5/19/2016)... and CAMBRIDGE, Massachusetts , May 19, ... in the development of pharmaceuticals and diagnostics based on the ... a new office in Cambridge, MA ... US. The office is located at Kendall Square, ... industry, well-known as the global hub for transforming scientific insights ...
(Date:5/18/2016)... May 19, 2016 ... Research Report initially provides a basic overview ... and manufacturing technology, post which the report ... in the market. Complete report ... pages providing 8 company profiles and 98 ...
Breaking Medicine Technology: